Zinc and Iron Absorption From Common Beans in Young Adult Women
NCT ID: NCT06327529
Last Updated: 2025-11-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
15 participants
INTERVENTIONAL
2024-05-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Visit 2 will establish the baseline distribution of naturally occurring zinc and iron isotopes in the blood, and will include the administration of water enriched in zinc of a specific naturally-occurring isotopic mass (zinc-68, 4 mg).
Visits 2-5 will be on consecutive days, while Visit 6 will be 14 days following Visit 5. Visits 3 and 4 will include breakfast, lunch, and dinner, each containing a small serving of beans that are enriched in specific isotopic masses of iron and zinc (2 mg each of zinc-67 and iron-57, or 1 mg each of zinc-70 and iron-58). Visits 5 and 6 are for blood sampling, to measure the zinc in blood plasma (Visit 5) and the iron that has reached a 14-day equilibrium in red blood cells (Visit 6). Participants will also be given a ASA24 24-hour dietary recall at visit 6 to return at visit 7.
Visits 6-9 will be on consecutive days, starting 28 days (the approximate length of one menstrual cycle) after Visit 3, while Visit 10 will be 14 days following Visit 9. The 28-day timing is needed to minimize the potential influence of natural variation in circulating hormones, on zinc metabolism. A second urine pregnancy test will be administered on Visit 10, to detect any pregnancies that would have occurred at the time of the study meals 2 weeks prior or earlier. Participants will also be given a ASA24 dietary recall at visit 9 to return at visit 10.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bean Variety 1
Enriched with Zinc-67, Iron-57
SER 118
Bean High in Phytic Acid and High in Inhibitory Polyphenols
Bean Variety 2
Enriched with Zinc-70, Iron-58
LMP 1001
Bean Low in Phytic Acid and High in Inhibitory Polyphenols
Bean Variety 3
Enriched with Zinc-67, Iron-57
LPA 586
Bean Low in Phytic Acid and Low in Inhibitory Polyphenols
Bean Variety 4
Enriched with Zinc-70, Iron-58
KAT B1
Bean High in Phytic Acid and Low in Inhibitory Polyphenols
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SER 118
Bean High in Phytic Acid and High in Inhibitory Polyphenols
LMP 1001
Bean Low in Phytic Acid and High in Inhibitory Polyphenols
LPA 586
Bean Low in Phytic Acid and Low in Inhibitory Polyphenols
KAT B1
Bean High in Phytic Acid and Low in Inhibitory Polyphenols
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 18.5 - 30 kg/m2
* Regular consumer of beans, i.e. ≥ 4 servings per month
* Usual iron intake estimated by Food Frequency Questionnaire to be less than the Recommended Daily Allowance (RDA) of 18 mg/d (8)
* Subject is willing and able to comply with the study protocols.
* Subject is willing to participate in all study procedures.
Exclusion Criteria
* Self-reported current or recent pregnancy (within the past 12 months)
* Self-reported recent termination of pregnancy (3 months if abortion in 1st or 2nd trimester, or 12 months if in 3rd trimester)
* Self-reported plans to become pregnant during the study period
* Self-reported cancer
* Self-reported surgery without the past 12 months
* Currently taking prescription drugs, other than for contraception, or any nutritional supplements
* Any daily iron supplementation within the past 12 months.
* Currently breastfeeding
* Any medical conditions affecting iron or zinc metabolism (such as hemochromatosis or sickle cell disease)
19 Years
24 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew G Hall, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, Davis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Nutrition
Davis, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Roberta R Holt, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2101814
Identifier Type: -
Identifier Source: org_study_id